ODAC Recommends Accelerated Approval of new Lymphoma Drug
The Oncologic Drugs Advisory Committee ( ODAC ) to the U.S. Food and Drug Administration (FDA) has voted unanimously to recommend that the FDA grant accelerated approval of Adcetris ( brentuximab vedotin ).
One of the "Easy Cancers"
A patient remembers the day he was diagnosed. Writing on a patient support group forum, he recalls, "I had one of the first oncologists I saw tell me 'you got the cancer I can treat. One pill a day and you carry on. Who's luckier than you?'"
New Drug Therapy Shows Promise in Treating Leukemia
Acute lymphoblastic leukemia is the most common type of childhood cancer. A new drug therapy holds promise in treating this particularly aggressive disease.
Preventing Children's Cancers From Returning
Acute lymphoblastic leukemia (ALL) used to be one of the deadliest cancers for children and young adults. Now it's one of the most curable, and cures rates are climbing.
Understanding of Alzheimer's Expanding
If we only knew exactly what caused Alzheimer's disease, it might be easier to treat. Scientists are making headway in both arenas.
New Findings on Hormone Replacement Therapy
You may remember some years ago when a large women's study was stopped because one of the therapies being tested was shown to actually increase the risk of breast cancer, heart attacks and strokes.
Closing in on the Leukemia Cure
The majority of patients with chronic myeloid leukemia recover using various cancer drug treatments. However, they are not cured, as a type of cancerous stem cell is resistant to the drugs.
"Turned Off" in Human Tumors
Researchers have gained new insights into one of the most aggressive tumors affecting humans, Burkitt's lymphoma cancer. There may be new ways of treating this painful and deadly disease with a new mechanism responsible for breaking down the genetic protections against tumors.
A Plan to Help the Pre-existing Condition Crowd
The U.S. Department of Health and Human Services (HHS) is increasing awareness about a health plan for uninsured Americans with pre-existing conditions created by the Affordable Care Act.
Un-Zombified Leukemia Cells
A team of University of Wisconsin-Madison researchers has successfully completed the first reprogramming of blood cells obtained from a patient with leukemia.